Screening for children from families with Rendu-Osler-Weber disease: From geneticist to clinician

Journal of Thrombosis and Haemostasis

Volumn 4, Issue 6, 2006, Pages 1237-1245

  Giordano, P ^a   Nigro, A ^a   Lenato, G M ^a   Guanti, G ^a   Suppressa, P ^a   Lastella, P ^a   De Mattia, D ^a   Sabbà, Carlo ^a  

^a UNIVERSITY OF BARI   (Italy)

Author keywords

Activin receptor like kinase 1 gene; Arteriovenous malformations; Endoglin gene; Hereditary hemorrhagic telangiectasia children; Mutation

Indexed keywords

ADOLESCENT; ADULT; ARTERIOVENOUS MALFORMATION; ARTICLE; BRAIN ARTERIOVENOUS MALFORMATION; BRAIN ISCHEMIA; CHILD; CLINICAL ARTICLE; CLINICAL EXAMINATION; CLINICAL PROTOCOL; COLOR ULTRASOUND FLOWMETRY; CONTRAST ECHOCARDIOGRAPHY; CONTROLLED STUDY; EPISTAXIS; FAMILY; FEMALE; GENE MUTATION; GENOTYPE; HETEROZYGOTE; HIGH RESOLUTION COMPUTER TOMOGRAPHY; HUMAN; INCIDENCE; INFANT; LIVER BLOOD VESSEL; LUNG ARTERIOVENOUS SHUNT; MALE; MEDICAL SPECIALIST; NUCLEAR MAGNETIC RESONANCE IMAGING; PHENOTYPE; PRIORITY JOURNAL; RENDU OSLER WEBER DISEASE; SCREENING;

ACTIVIN RECEPTORS, TYPE II; ADOLESCENT; ANTIGENS, CD; ARTERIOVENOUS MALFORMATIONS; CHILD; CHILD, PRESCHOOL; CLINICAL MEDICINE; FEMALE; GENETIC SCREENING; GENETICS, MEDICAL; HEPATIC ARTERY; HEPATIC VEINS; HUMANS; INFANT; INTRACRANIAL ARTERIOVENOUS MALFORMATIONS; MALE; MUTATION; PHENOTYPE; PULMONARY ARTERY; PULMONARY VEINS; RECEPTORS, CELL SURFACE; TELANGIECTASIA, HEREDITARY HEMORRHAGIC;

EID: 33646810085     PISSN: 15387933     EISSN: 15387836     Source Type: Journal    
DOI: 10.1111/j.1538-7836.2006.01934.x     Document Type: Article

References (63)

1. Begbie ME, Wallace GM, Shovlin CL. Hereditary hemorrhagic telangiectasia (Osler-Weber-Rendu syndrome): A view from the 21st century. Postgrad Med J 2003; 79: 18-24.
2. Haitjema T, Westermann CJ, Overtoom TT. Hereditary hemorrhagic telangiectasia (Osler-Weber-Rendu disease): New insights in pathogenesis, complications and treatment. Arch Intern Med 1996; 165: 714-9.
3. Marchuk D, Guttmacher A, Penner JA, Ganguly P. Report on the workshop on hereditary hemorrhagic telangiectasia, July 10-11, 1997. Am J Med Genet 1998; 76: 269-73.
4. Kjeldesen AD, Vase P, Green A. Hereditary haemorrhagic telangiectasia: A population-based study of prevalence and mortality in Danish patients. J Intern Med 1999; 245: 31-9.
5. Easey AJ, Wallace GMF, Hughes JMB, Jackson JE, Taylor WJ, Shovlin CL. Should asymptomatic patients with hereditary haemorrhagic telangiectasia (HHT) be screened for cerebral vascular malformations? Data from 22 061 years of HHT patient life. J Neurol Neurosurg Psychiatry 2003; 74: 743-8.
6. McAllister KM, Johnson DW, Gallione CJ, Baldwin MA, Jackson CE, Helmbold EA, Markel DS, McKinnon WC, Murrell J, McKormick MK, Pericak-Vance MA, Heutink P, Oostra BA, Haitjema T, Westermann CJJ, Portoeus ME, Guttmacher AE, Letarte M, Marchuk DA. Endoglin, a TGF-beta binding protein of endothelial cells, is the gene for hereditary haemorrhagic telangiectasia type 1. Nat Genet 1994; 8: 345-51.
7. Johnson DW, Berg JN, Baldwin MA, Gallione CJ, Marondel I, Yoon SJ, Stenzel TT, Speer M, Pericak-Vance MA, Diamond A, Guttmacher AE, Jackson CE, Attisano L, Kucherlapati R, Portoeus ME, Marchulk DA. Mutations in the activin receptor-like kinase 1 gene in hereditary haemorrhagic telangiectasia type 2. Nat Genet 1996; 13: 189-95.
8. Gallione CJ, Repetto GM, Legius E, Rustgi AK, Schelley SL, Tejpar S, Mitchell G, Drouin E, Westermann CJ, Marchuk DA. A combined syndrome of juvenile polyposis and hereditary haemorrhagic telangiectasia associated with mutations in MADH4 (SMAD4). Lancet 2004; 363: 852-9.
9. Cole SG, Begbie ME, Wallace GM, Shovlin CL. A new locus for hereditary haemorrhagic telangiectasia (HHT3) maps to chromosome 5. J Med Genet 2005; 42: 577-82.
10. Toporsian M, Gros R, Kabir MG, Vera S, Govindaraju K, Eidelman DH, Husain M, Letarte M. A role for endoglin in coupling eNOS activity and regulating vascular tone revealed in hereditary hemorrhagic telangiectasia. Circ Res 2005; 96: 684-92.
11. Fernandez-Lopez A, Sanz-Rodrigues F, Zarrabeitia R, Perez-Molino A, Hebbel RB, Nguyen J, Botella LM, Bernabeu C. Blood outgrowth endothelial cells from Hereditary Haemorrhagic Telagectasia patients reveal abnormalities compatible with vascular lesion. Cardiovasc Res 2005; 68: 235-48.
12. Lastella P, SabbàC, Lenato GM, Resta N, Lattanzi W, Gallitelli M, Cirulli A, Guanti G. Endoglin gene mutations and polymorphisms in Italian patients with hereditary haemorrhagic telangiectasia. Clin Genet 2003; 63: 536-40.
13. Gallione CJ, Scheessele EA, Reinhardt D, Duits AJ, Berg JN, Westermann CJJ, Marchuk DA. Two common endoglin mutations in families with hereditary hemorrhagic telangiectasia in the Netherlands Antilles: evidence for a founder effect. Hum Genet 2000; 107: 40-4.
14. Lesca G, Plauchu H, Coulet F, Lefebvre S, Plessis G, Odent S, Riviere S, Leheup B, Goizet C, Carette MS, Cordier JF, Pinson S, Soubrier F, Calendar A, Giraud S. Molecular screening of ALK1/ACVRL1 and ENG genes in hereditary hemorrhagic telangiectasia in France. Hum Mutat 2004; 23: 289-99.
15. Brusgaard K, Kjeldsen AD, Poulsen L, Moss H, Vase P, Rasmussen K, Kruse TA, Horder M. Mutations in endoglin and in activin receptor-like kinase 1 among Danish patients with hereditary haemorrhagic telangiectasia. Clin Genet 2004; 66: 556-61.
16. Shovlin CL, Guttmacher AE, Buscarini E, Faughnan ME, Hyland RH, Westermann CJJ, Kjeldsen AD, Plauchu H. Diagnostic criteria for hereditary hemorrhagic telangiectasia (Rendu-Osler-Weber syndrome). Am J Med Genet 2000; 91: 66-7.
17. Sabba C. A rare and misdiagnosed bleeding disorder: Hereditary hemorrhagic telangiectasia. J Thromb Haemost 2005; 3: 2201-10.
18. Morgan T, Mc Donald J, Anderson C, Ismail M, Miller F, Mao R, Madan A, Barnes P, Hudgins L, Manning M. Intracranial hemorrhage in infants and children with hereditary hemorrhagic telangiectasia (Osler-Weber-Rendu syndrome). Pediatrics 2002; 109: E12.
19. Faughnan ME, Ashraf Thabet BA, Mai-Zahav M, Colombo M, McLusky I, Hyland RH, Pugash RA, Chait P, Henderson KJ, White Jr RI. Pulmonary arteriovenous malformations in children: Outcomes of transcatheter embolotherapy. J Pediatr 2004; 145: 826-31.
20. Ianora AA, Memeo M, SabbàC, Cirulli A, Rotondo A, Angelelli G. Hereditary hemorrhagic telangiectasia: Multi detector row helical CT assessment of hepatic involvement. Radiology 2004; 230: 250-9.
21. Kjeldsen AD, Kjeldsen J. Gastrointestinal bleeding in patients with hereditary hemorrhagic telangiectasia. Am J Gastroenterol 2000; 95: 415-8.
22. Lenato GM, Lastella P, Di Giacomo MC, Resta N, Soppressa P, Pasculli G, SabbàC, Guanti G. DHPLC-based mutation analysis of ENG and ALK-1 genes in the HHT Italian population. Hum Mutat 2006; 27: 213-4.
23. Bayrak-Toydemir P, Mao R, Lewin S, Mc Donald J. Hereditary hemorrhagic telangiectasia: An overview of diagnosis and management in the molecular era for clinicians. Genet Med 2004; 6: 175-91.
24. Cohen JH, Faughnan ME, Letarte M, Vandezande K, Kennedy SJ, Krahn MD. Cost comparison of genetic and clinical screening in families with hereditary hemorrhagic telangiectasia. Am J Med Genet A 2005; 137: 153-60.
25. Berg J, Porteous M, Reinhardt D, Gallione C, Holloway S, Umasunthar T, Lux A, McKinnon W, Marchuk D, Guttmacher A. Hereditary haemorrhagic telangiectasia: A questionnaire based study to delineate the different phenotypes caused by endoglin and ALK1 mutations. J Med Genet 2003; 40: 585-90.
26. Letteboer TG, Mager HJ, Snijder RJ, Koeleman BP, Lindhout D, Ploos van Amstel HK, Westermann KJ. Genotype-phenotype relationship in hereditary hemorrhagic telangiectasia. J Med Genet 2006; 43: 371-7.
27. Abdalla SA, Geisthoff UW, Bonneau D, Plauchu H, McDonald J, Kennedy S, Faughnan ME, Letarte M. Visceral manifestations in hereditary haemorrhagic telangiectasia type 2. J Med Genet 2003; 40: 494-502.
28. Kjeldsen AD, Moller TR, Brusgaard K, Vase P, Andersen PE. Clinical symptoms according to genotype amongst patients with hereditary haemorrhagic telangiectasia. J Int Med 2005; 258: 349-55.
29. Bayrak-Toydemir P, McDonald J, Markewitz B, Lewin S, Miller F, Chou LS, Gedge F, Tang W, Coon H, Mao R. Genotype-phenotype correlation in hereditary haemorrhagic telangiectasia: Mutations and manifestations. Am J Med Genet A 2006; 140: 463-70.
30. Shovlin CL, Letarte M. Hereditary haemorrhagic telangiectasia and pulmonary arteriovenous malformations: Issues in clinical management and review of pathogenic mechanisms. Thorax 1999; 54: 714-29.
31. Dutton JA, Jackson JE, Hughes JM, Whyte MK, Peters AM, Ussov W, Allison DJ. Pulmonary arteriovenous malformations: Results of treatment with coil embolization in 53 patients. Am J Roentgenol 1995; 165: 119-25.
32. Chilvers ER, Whyte MK, Jackson JE, Allison DJ, Hughes JM. Effect of percutaneous transcatheter embolization on pulmonary function, right-to-left shunt, and arterial oxygenation in patients with pulmonary arteriovenous malformations. Am Rev Respir Dis 1990; 142: 420-25.
33. Bernstein HS, Brook MM, Silverman NH, Bristow J. Development of pulmonary arteriovenous fistulae in children after cavopulmonary shunt. Circulation 1995; 92: 309-14.
34. Larsson ES, Solymar L, Eriksson BO, de Wahl Granelli A, Mellander M. Bubble contrast echocardiography in detecting pulmonary arteriovenous malformations after modified Fontan operations. Cardiol Young 2001; 11: 505-11.
35. Chao HS, Chern MS, Chen YC, Chang SC. Recurrence of pulmonary arteriovenous malformations in a female with hereditary hemorrhagic telangiectasia. Am J Med Sci 2004; 327: 294-8.
36. Lee WL, Graham AF, Pugash RA, Hutchison SJ, Grande P, Hyland RH, Faughnan ME. Contrast echocardiography remains positive after treatment of pulmonary arteriovenous malformations. Chest 2003; 123: 351-8.
37. Nanthakumar K, Graham AT, Robinson TI, Grande P, Pugash RA, Clarke JA, Hutchison SJ, Mandzia JL, Hyland RH, Faughnan ME. Contrast echocardiography for detection of pulmonary arteriovenous malfromations. Am Heart J 2001; 141: 243-6.
38. Cottin V, Plauchu H, Bayle JY, Barthelet M, Revel D, Cordier JF. Pulmonary arteriovenous malformations in patients with hereditary hemorrhagic telangiectasia. Am J Respir Crit Care Med 2004; 169: 994-1000.
39. Andersen PE, Kjeldsen AD, Oxhoj H, Vase P, White Jr RI. Embolotherapy for pulmonary arteriovenous malformations in patients with hereditary hemorrhagic telangiectasia (Rendu-Osler-Weber syndrome). Acta Radiol 1998; 39: 723-6.
40. Kjeldsen AD, Oxhoj H, Andersen PE, Elle B, Jacopsen JP, Vase P. Pulmonary arteriovenous malformations. Screening procedures and pulmonary angiography in patients with hereditary hemorrhagic telangiectsia. Chest 1999; 116: 432-40.
41. Faughnan ME, Hyland RH, Nanthakumar K, Redelmeier DA. Screening in hereditary hemorrhagic telangiectasia patients. Chest 2000; 118: 566-7.
42. Remy J, Remy-Jardin M, Giraud F, Wattinne L. Angioarchitecture of pulmonary arteriovenous malformations: Clinical utility of three-dimensional helical CT. Radiology 1994; 191: 657-64.
43. Khursid I, Downie GH. Pulmonary arteriovenous malformation. Postgrad Med J 2002; 78: 191-7.
44. Gossage JR, Kanj G. Pulmonary arteriovenous malformations. Am J Respir Crit Care Med 1998; 158: 643-61.
45. White Jr RI, Lunch-Nyhan A, Terry P, Buescher PC, Fermlett EJ, Charnas L, Shuman K, Kim W, Kinnison M, Mitchell SE. Pulmonary arteriovenous malformations: Techniques and long-term outcome of embolotherapy. Radiology 1988; 169: 663-9.
46. White Jr RI, Pollak JS, Wirth JA. Pulmonary arteriovenous malformations: diagnosis and transcatheter embolotherapy. J Vasc Intervent Radiol 1996; 7: 787-804.
47. Dennis MS. Neurological complications of pulmonary arteriovenous malformations. BMJ (Clin Res Ed) 1985; 290: 1392-3.
48. Kjeldsen AD, OxHoj H, Andersen PE, Green A, Vase P. Prevalence of pulmonary arteriovenous malformations (PAVMs) and occurrence of neurological symptoms in patients with hereditary haemorrhagic telangiectasia (HHT). J Intern Med 2000; 248: 255-62.
49. Post MC, Thijs V, Schoenewille WJ, Budts W, Snijder RJ, Plokker HK, Westermann CJ. Embolization of pulmonary arteriovenous malformations and decrease in prevalence of migraine. Neurology 2006; 66: 202-5.
50. Post MC, Letteboer TG, Mager JJ, Plokker TH, Kelder JC, Westermann CJ. A pulmonary right-to-left shunt in patients with hereditary hemorrhagic telangiectasia is associated with an increased prevalence of migraine. Chest 2005; 128: 2485-9.
51. Garcia Tsao G, Korzenik JR, Young L, Henderson KJ, Jain D, Bird B, Pollak JS, White Jr RI. Liver disease in patients with hereditary hemorrhagic telangiectasia. N Engl J Med 2000; 28: 931-6.
52. Pfitzmann R, Heise M, Langrehr JM, Jonas S, Steinmuller T, Podrabsky P, Ewert R, Settmacher U, Neuhaus P. Liver transplantation for treatment of intrahepatic Osler's disease: First experiences. Transplantation 2001; 72: 237-41.
53. Hillert C, Broering DC, Gundlach M, Knoefel WT, Izbicki JR, Rogiers X. Hepatic involvement in hereditary hemorrhagic telangiectasia: An unusual indication for liver transplantation. Liver Transpl 2001; 7: 266-8.
54. Caselitz M, Bahr MJ, Bleck JS, Chaven A, Manns MP, Wagner S, Gebel M. Sonographic criteria for the diagnosis of hepatic involvement in hereditary hemorrhagic telangiectasia (HHT). Hepatology 2003; 37: 1139-46.
55. Buscarini E, Danesino C, Olivieri C, Lupinacci G, De Grazia F, Reduzzi L, Blotta P, Gazzaniga P, Pagella F, Grosso M, Pungiglione G, Buscarini L, Plauchu H, Zambelli A. Doppler ultrasonographic grading of hepatic vascular malformations in hereditary hemorrhagic telangiectasia -results of extensive screening. Ultraschall Med 2004: 25; 348-55.
56. Guidetti B, Delitala A. Intracranial arteriovenous malformations. Conservative and surgical treatment. J Neurosurg 1980; 53: 149-52.
57. Humphreys RP, Hendrick EB, Hoffman HJ. Arteriovenous malformations of the brainstem in childhood. Childs Brain 1984; 11: 1-11.
58. Garza-Mercado R, Cavazos E, Tamez-Montes D. Cerebral arteriovenous malformations in children and adolescents. Surg Neurol 1987; 27: 131-40.
59. Fulbright RK, Chaloupka JC, Putman CM, Sze GK, Merriam MM, Lee GK, Fayad PB, Awad IA, White Jr RI. MR of hereditary hemorrhagic telangiectasia: prevalence and spectrum of cerebrovascular malformations. Am J Neuroradiol 1998; 19: 477-84.
60. Bourdeau A, Cymerman U, Paquet ME, Meschino W, McKinnon WC, Guttmacher AE, Becker AL, Letarte M. Endoglin expression is reduced in normal vessels but still detectable in arteriovenous malformations of patients with hereditary hemorrhagic telangiectasia type 1. Am J Pathol 2000; 156: 911-23.
61. Challa VR, Moody DM, Brown WR. Vascular malformations of the central nervous system. J Neuropathol Exp Neurol 1995; 54: 609-21.
62. Bourdeau A, Faughnan ME, Letarte M. Endoglin-deficient mice, a unique model to study hereditary hemorrhagic telangiectasia. Trends Cardiovasc Med 2000; 10: 279-85.
63. Srinivasan S, Hanes MA, Dickens T, Porteous ME, Oh SP, Hale LP, Marchuk DA. A mouse model for hereditary hemorrhagic telangiectasia (HHT) type 2. Hum Mol Genet 2003; 12: 473-82.